Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
| Autores principales: | , , |
|---|---|
| Formato: | Conference item |
| Lenguaje: | English |
| Publicado: |
American Heart Association
2022
|
| Sumario: |
|---|